Potent Human Monoclonal Antibodies Against BoNT A, B and E Suited for Mass Production and Treatment of Large Populations (Research, Development, Test and Evaluation - Defense Wide)
| FY | 2010 |
| State | PA |
| Cost | $1,000,000.00 |
| Status | |
| Chamber | |
| Appropriation | DEF |
| House | Gerlach |
| Senate |